Livnat Jerby-Arnon
发表
Thomas M. Norman,
N. Friedman,
R. Raychowdhury,
2016,
Cell.
Monika S. Kowalczyk,
A. Regev,
P. Sorger,
2018,
Cell.
Eytan Ruppin,
Paul A. Clemons,
Brinton Seashore-Ludlow,
2014,
Cell.
A. Regev,
Le Cong,
T. Jacks,
2019,
Cell reports.
Alyssa R. Richman,
B. Haas,
A. Regev,
2019,
bioRxiv.
Adam A. Friedman,
E. Ruppin,
K. Flaherty,
2018,
bioRxiv.
A. Regev,
Livnat Jerby-Arnon,
2022,
Nature Biotechnology.
A. Regev,
Livnat Jerby-Arnon,
2020,
bioRxiv.
A. Regev,
J. Utikal,
S. Haferkamp,
2020,
Nature Medicine.
A. Regev,
T. Brinker,
P. Sorger,
2020,
Nature Medicine.
Alyssa R. Richman,
Brian L. Shaw,
A. Regev,
2021,
Cell.
A. Regev,
W. Hahn,
O. Rozenblatt-Rosen,
2022,
Nature Biotechnology.
A. Regev,
D. Schadendorf,
B. Cleary,
2021,
Nature Genetics.
A. Regev,
W. Hahn,
O. Rozenblatt-Rosen,
2020,
bioRxiv.
Aviv Regev,
Mario L. Suvà,
Nikhil Wagle,
2019,
Nature Medicine.
A. Regev,
J. Utikal,
S. Haferkamp,
2019,
Nature Medicine.
I. Weissman,
C. Curtis,
J. Sage,
2021,
Nature.
Hannah R. Weisman,
Alyssa R. Richman,
B. Haas,
2021,
Nature Medicine.
A. Regev,
O. Rozenblatt-Rosen,
A. Madi,
2021,
bioRxiv.
E. Ruppin,
J. Lee,
Livnat Jerby-Arnon,
2021,
Cancer Research.
E. Ruppin,
P. Meltzer,
C. Benes,
2018,
Nature Communications.
A. Regev,
J. Utikal,
S. Haferkamp,
2019,
Nature Medicine.
Timothy L. Tickle,
Charles H. Yoon,
A. Regev,
2020,
Nature Network Boston.
Eytan Ruppin,
Sridhar Hannenhalli,
Paul S. Meltzer,
2018,
Nature Communications.
Adam A. Friedman,
E. Ruppin,
K. Flaherty,
2018,
bioRxiv.
Abstract PR01: A cancer cell program promotes T-cell exclusion and resistance to checkpoint blockade
A. Regev,
C. Rodman,
P. Shah,
2020,
Cancer Research.
Livnat Jerby-Arnon,
Dixian Zhu,
2024,
2402.06104.
Adam A. Friedman,
E. Ruppin,
K. Flaherty,
2018,
bioRxiv.